Boston Bio Systems has informed that a meeting of the board of directors of the Company will be held on February 06, 2017, for consideration of unaudited results of the Company for quarter Ended on December 31, 2016. Further, the trading window will be closed for Directors, Officers, Employees and Auditors of the Company, including their dependents till the declaration of unaudited financial results for quarter Ended on December 31, 2016 in the board meeting of the Company to be held on February 06, 2017 and two days thereafter they all are not permitted to deal in the shares of the Company.
The above information is a part of company’s filings submitted to BSE.